Moreover, Fujisawa et al. (2015) reported the efficacy of the ATR inhibitor VE-821 with low and high LET radiation sources in human tumour cells, indicating inhibition of this protein as an attractive therapeutic strategy in combination with differing radiation qualities [37]. The gene discussed is ATR; the disease is neoplasm.